X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (58) 58
female (47) 47
index medicus (47) 47
oncology (43) 43
middle aged (39) 39
adult (33) 33
breast cancer (32) 32
aged (24) 24
male (21) 21
breast neoplasms - pathology (18) 18
chemotherapy (18) 18
breast neoplasms - drug therapy (16) 16
clinical neurology (15) 15
disease-free survival (14) 14
analysis (13) 13
cancer (13) 13
hematology, oncology and palliative medicine (13) 13
research (13) 13
neurosciences (12) 12
italy (11) 11
medicine & public health (11) 11
prognosis (11) 11
care and treatment (10) 10
genotype (10) 10
breast neoplasms - metabolism (9) 9
breast neoplasms - mortality (9) 9
risk factors (9) 9
treatment outcome (9) 9
young adult (9) 9
genetic aspects (8) 8
health aspects (8) 8
kaplan-meier estimate (8) 8
metastasis (8) 8
neoadjuvant therapy (8) 8
aged, 80 and over (7) 7
cancer patients (7) 7
carcinoma (7) 7
docetaxel (7) 7
genetic predisposition to disease (7) 7
medicine (7) 7
mutation (7) 7
obstetrics and gynecology (7) 7
oncology, experimental (7) 7
receptors, estrogen - metabolism (7) 7
survival (7) 7
therapy (7) 7
women (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
breast neoplasms - therapy (6) 6
disease progression (6) 6
estrogen-receptor (6) 6
follow-up studies (6) 6
immunohistochemistry (6) 6
male breast cancer (6) 6
neoadjuvant chemotherapy (6) 6
neoplasm metastasis (6) 6
neoplasm staging (6) 6
prevalence (6) 6
retrospective studies (6) 6
risk (6) 6
adolescent (5) 5
alleles (5) 5
bevacizumab (5) 5
brca1 (5) 5
breast neoplasms - genetics (5) 5
breast neoplasms - surgery (5) 5
capecitabine (5) 5
case-control studies (5) 5
child (5) 5
clinical trials (5) 5
cyclophosphamide (5) 5
cyclophosphamide - administration & dosage (5) 5
efficacy (5) 5
epidemiology (5) 5
estrogen receptor (5) 5
fluorouracil - administration & dosage (5) 5
genes (5) 5
highlights (5) 5
medical prognosis (5) 5
metronomic chemotherapy (5) 5
migraine (5) 5
obstetrics & gynecology (5) 5
patients (5) 5
primary therapy (5) 5
proportional hazards models (5) 5
receptor, erbb-2 - metabolism (5) 5
receptors, progesterone - metabolism (5) 5
research article (5) 5
time factors (5) 5
adjuvant treatment (4) 4
administration, metronomic (4) 4
antineoplastic agents, hormonal - therapeutic use (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
breast neoplasms, male - genetics (4) 4
cancer therapies (4) 4
carcinoma, ductal, breast - mortality (4) 4
carcinoma, lobular - mortality (4) 4
carcinoma, lobular - therapy (4) 4
chemotherapy, adjuvant - methods (4) 4
combination (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Therapeutic advances in medical oncology, ISSN 1758-8340, 2019, Volume 11, p. 1758835919894105
Approximately 50% of HER2 positive breast cancer cases are also estrogen receptor (ER) positive. Data supports a role for close cross-talk between the ER and... 
Journal Article
by Galimberti, Viviana and Cole, Bernard F and Viale, Giuseppe and Veronesi, Paolo and Vicini, Elisa and Intra, Mattia and Mazzarol, Giovanni and Massarut, Samuele and Zgajnar, Janez and Taffurelli, Mario and Littlejohn, David and Knauer, Michael and Tondini, Carlo and Di Leo, Angelo and Colleoni, Marco and Regan, Meredith M and Coates, Alan S and Gelber, Richard D and Goldhirsch, Aron and Boyle, Fran and Jerusalem, Guy and Stahel, Rolf and Aebi, Stefan and Green, Michael and Karlsson, Per and Kössler, Ingrid and Láng, Istvan and Hiltbrunner, Anita and Bernhard, Jürg and Fournarakou, Stamatina and Kammler, Roswitha and Maibach, Rudolf and Rabaglio, Manuela and Ribi, Karin and Roschitzki, Heidi and Roux, Susanne and Ruepp, Barbara and Mahoney, Caitlin and Price, Karen and Blacher, Lynette and Scolese, Tara and Scott, Karolyn and Lippert, Sandra and Zielinski, Theresa and Mastropasqua, Mauro and Andrighetto, Stefania and Dell'Orto, Patrizia and Renne, Giuseppe and Pruneri, Giancarlo and Dellapasqua, Silvia and Iorfida, Monica and Cancello, Giuseppe and Montagna, Emilia and Cardillo, Anna and Peruzzotti, Giulia and Ghisini, Raffaella and Luini, Alberto and Veronesi, Umberto and Intra, Mattia and Gentilini, Oreste and Zurrida, Stefano and Curigliano, Giuseppe and Nole, Franco and Orecchia, Roberto and Leonardi, Marisa Cristina and Baratella, Paola and Chifu, Camelia and Sargenti, Manuela and Crivellari, Diana and Morassut, Sandro and Mileto, Mario and Piccoli, Erica and Veronesi, Andreas and Magri, Marisa Donatella and Buonadonna, Angelo and Candiani, Ezio and Carbone, Antonino and Perin, Tiziana and Volpe, Rachele and Roncadin, Mario and Arcicasa, Mauro and Coran, Francesco and Lagrassa, Manuela and Recalcati, Angelo and Limonta, Maria Emanuela and Tricomi, Paolo and Fenaroli, Privato and Candiago, Elisabetta and Cattaneo, Laura and Gianatti, Alberto and Santini, Donatella and Maweja, Sylvie and Delvenne, Philippe and Rorive, Andrée and Collignon, Joëlle and Garbay, Jean-Remi and Mathieu, Marie-Christine and Galatius, Hanne and Hoffmann, Jack and Schousen, Peer and ... and International Breast Cancer Study Group Trial 23-01 and Int Breast Canc Study Grp Trial 23
The Lancet Oncology, ISSN 1470-2045, 10/2018, Volume 19, Issue 10, pp. 1385 - 1393
We previously reported the 5-year results of the phase 3 IBCSG 23-01 trial comparing disease-free survival in patients with breast cancer with one or more... 
SURGERY | WOMEN | MULTICENTER | METASTASIS | ONCOLOGY | LYMPH-NODES | BIOPSY | RECURRENCE | EORTC 10981-22023 AMAROS | Care and treatment | Cancer patients | Breast cancer | Analysis | Surgery
Journal Article
Journal Article
Cancer Letters, ISSN 0304-3835, 2017, Volume 400, pp. 276 - 281
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 12/2010, Volume 124, Issue 3, pp. 689 - 699
Journal Article
Expert Review of Anticancer Therapy, ISSN 1473-7140, 08/2018, Volume 18, Issue 8, pp. 805 - 814
Background: The aim of this study was to record the opinions of Italian oncologists about the use of oral vinorelbine administered metronomically in patients... 
vinorelbine | metronomic chemotherapy | immunomodulation | Advanced breast cancer | antiangiogenesis | EFFICACY | CYCLOPHOSPHAMIDE | SAFETY | BEVACIZUMAB | 1ST-LINE CHEMOTHERAPY | METHOTREXATE | PACLITAXEL | PHASE-III TRIAL | CAPECITABINE | ONCOLOGY | PRETREATED PATIENTS | Index Medicus
Journal Article